NY-ESO-1/LAGE-1 class I/II peptide vaccine (Baylor College of Medicine/NCI)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNY-ESO-1/LAGE-1 class I/II peptide vaccine (Baylor College of Medicine/NCI)

Drug Alias NameNY-ESO-1/LAGE1 peptide vaccine (Baylor College/NCI)

ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionCancer/testis antigen 2 modulatorsCancer/testis antigen 1 modulators

TargetsCancer/testis antigen 2Cancer/testis antigen 1

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBaylor College Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Cancer Institute Baylor College Of Medicine

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A